Ajax-Loading

Eli Lilly and Company - Debt To Equity Ratio

Eli Lilly and Company's Fiscal Year is From January To December.

The item "Debt-To-Equity-Ratio" stands at 1.79 as of 09/30/2025, the lowest value since 09/30/2023.

As of the end of Eli Lilly and Company's third quarter, the item "Debt To Equity Ratio" stands at 1.79. This represents a decrease of -18.19 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -18.25 percent compared to the value the year prior.
The 1 year change in percent is -18.25.
The 3 year change in percent is 13.23.

The Serie's long term average value is 1.97. It's latest available value, on 09/30/2025, is 9.20 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is +17.16%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -26.88%.

Debt To Equity Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Debt To Equity Ratio486,508,953,600.00
LogoAbbVie Inc - Debt To Equity Ratio399,570,305,024.00
LogoRoche Holding AG - Debt To Equity Ratio317,433,206,677.55
LogoAstraZeneca PLC - Debt To Equity Ratio280,205,508,085.11
LogoNovartis AG - Debt To Equity Ratio255,096,620,580.91